Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, has received a Canadian ...

Add Yahoo as a preferred source to see more of our stories on Google. A decade of patient follow-up finds a combo of two immunotherapy drugs can greatly extend survival for people with advanced ...

An innovative treatment for bladder cancer successfully prevented the recurrence of tumors and improved survival rates following surgery.

New findings from a clinical trial highlight the potential for neoadjuvant immunotherapy to eliminate the need for surgery in patients with a particular type of cancer, helping them maintain a higher ...

Some people with early stage cancers may be able to skip surgery after being treated with the immunotherapy drug dostarlimab, ...

The FDA’s Oncologic Drugs Advisory Committee has voted to restrict the use of nivolumab and pembrolizumab immunotherapy drugs based on the programmed death-ligand 1 expression levels of patients, ...

Every participant in a new bowel cancer immunotherapy trial remained cancer-free nearly three years after receiving ...

Pancreatic ductal adenocarcinoma is one of the deadliest cancer types, with a five-year survival rate of 13%. There are only ...

Immunotherapy is a cancer treatment that harnesses the body’s immune system to fight cancer. It helps the immune system recognize and attack cancer cells, which can sometimes be hidden from the body’s ...

Health minister hopes a key injectable cancer drug will be available in all five trusts "as soon as possible".

There is a classic image in cancer treatment of a patient triumphantly ringing a bell to commemorate the end of chemotherapy ...

A decade of patient follow-up finds a combo of two immunotherapy drugs can greatly extend survival for people with advanced melanomas. In 2011, a diagnosis of advanced, metastatic melanoma typically ...